Corcept Therapeutics (CORT)
111.62
-1.18 (1.05%)
Upcoming Events
Latest Headlines
S&P announces major changes in S&P 100, S&P 500, S&P 400
September 4, 2026 5:32 PM - StreetInsider
S&P Dow Jones Indices adds Bloom Energy to S&P 500 index
September 4, 2026 5:17 PM - StreetInsider
Form 4 CORCEPT THERAPEUTICS For: Aug 26 Filed by: Park Kimberly
August 28, 2026 4:31 PM - SEC Filing
Form 4 CORCEPT THERAPEUTICS For: Aug 25 Filed by: Maduck Sean
August 27, 2026 4:30 PM - SEC Filing
Form 144 CORCEPT THERAPEUTICS Filed by: Park Kimberly
August 26, 2026 4:15 PM - SEC Filing
Form 144 CORCEPT THERAPEUTICS Filed by: Maduck Sean
August 25, 2026 5:25 PM - SEC Filing
Form 4 CORCEPT THERAPEUTICS For: Aug 18 Filed by: MAHONEY DAVID L
August 20, 2026 4:30 PM - SEC Filing
Form 4 CORCEPT THERAPEUTICS For: Aug 14 Filed by: WILSON JAMES N
August 18, 2026 4:30 PM - SEC Filing
Form 4 CORCEPT THERAPEUTICS For: Aug 14 Filed by: Maduck Sean
August 18, 2026 4:30 PM - SEC Filing
Form 4 CORCEPT THERAPEUTICS For: Aug 17 Filed by: Robb Gary Charles
August 18, 2026 4:30 PM - SEC Filing
Form 144 CORCEPT THERAPEUTICS Filed by: MAHONEY DAVID L
August 18, 2026 10:12 AM - SEC Filing
Truist Securities Assumes Corcept Therapeutics (CORT) at Buy
August 18, 2026 5:07 AM - StreetInsider
Form 144 CORCEPT THERAPEUTICS Filed by: Robb Gary Charles
August 17, 2026 4:06 PM - SEC Filing
Form 4 CORCEPT THERAPEUTICS For: Aug 12 Filed by: Robb Gary Charles
August 14, 2026 4:36 PM - SEC Filing
Form SCHEDULE 13G/A CORCEPT THERAPEUTICS Filed by: RENAISSANCE TECHNOLOGIES LLC
August 13, 2026 4:21 PM - SEC Filing
Form 4 CORCEPT THERAPEUTICS For: Aug 10 Filed by: Maduck Sean
August 12, 2026 4:28 PM - SEC Filing
Form 4 CORCEPT THERAPEUTICS For: Aug 10 Filed by: Guyer William
August 12, 2026 4:26 PM - SEC Filing
Form 4 CORCEPT THERAPEUTICS For: Aug 04 Filed by: Guyer William
August 12, 2026 11:03 AM - SEC Filing
Form 4 CORCEPT THERAPEUTICS For: Aug 04 Filed by: Guyer William
August 6, 2026 6:45 PM - SEC Filing
Form 4 CORCEPT THERAPEUTICS For: Aug 03 Filed by: Maduck Sean
August 5, 2026 5:51 PM - SEC Filing
Form 4 CORCEPT THERAPEUTICS For: Aug 03 Filed by: Lyon Joseph Douglas
August 5, 2026 5:49 PM - SEC Filing
Form 144 CORCEPT THERAPEUTICS Filed by: Guyer William
August 4, 2026 3:07 PM - SEC Filing
Form 4 CORCEPT THERAPEUTICS For: Jul 30 Filed by: Mokari Atabak
August 3, 2026 4:31 PM - SEC Filing
Form 144 CORCEPT THERAPEUTICS Filed by: Lyon Joseph Douglas
August 3, 2026 12:17 PM - SEC Filing
Form 144 CORCEPT THERAPEUTICS Filed by: Mokari Atabak
July 30, 2026 4:04 PM - SEC Filing
Corcept Therapeutics (CORT) PT Raised to $165 at Piper Sandler
July 30, 2026 7:09 AM - StreetInsider
Corcept Therapeutics (CORT) PT Raised to $165 at H.C. Wainwright
July 30, 2026 6:45 AM - StreetInsider
Corcept Therapeutics (CORT) Tops Q2 EPS by 35c ; Offers Guidance
July 30, 2026 1:48 AM - StreetInsider
Form 10-Q CORCEPT THERAPEUTICS For: Jun 30
July 29, 2026 4:10 PM - SEC Filing
Form 8-K CORCEPT THERAPEUTICS For: Jul 29
July 29, 2026 4:08 PM - SEC Filing
Corcept Therapeutics Announces Second Quarter Financial Results and Provides Corporate Update
July 29, 2026 4:05 PM - BizWire
Corcept Therapeutics (CORT) PT Raised to $150 at Canaccord
July 29, 2026 6:42 AM - StreetInsider
Corcept Therapeutics (CORT) call put ratio 1.4 calls to 1 put as share price up 5.2%
July 27, 2026 2:43 PM - StreetInsider
Wolfe Research Downgrades Corcept Therapeutics (CORT) to Underperform
July 27, 2026 1:22 AM - StreetInsider
Corcept Therapeutics to Announce Second Quarter Financial Results, Provide Corporate Update and Host Conference Call
July 22, 2026 4:05 PM - BizWire
Form 4 CORCEPT THERAPEUTICS For: Jul 15 Filed by: WILSON JAMES N
July 17, 2026 6:39 PM - SEC Filing
Form 4 CORCEPT THERAPEUTICS For: Jul 15 Filed by: Mokari Atabak
July 17, 2026 6:32 PM - SEC Filing
Form 4 CORCEPT THERAPEUTICS For: May 27 Filed by: Robb Gary Charles
July 8, 2026 8:01 PM - SEC Filing
Form 4 CORCEPT THERAPEUTICS For: Jul 07 Filed by: Guyer William
July 8, 2026 7:55 PM - SEC Filing
Form 144 CORCEPT THERAPEUTICS Filed by: Guyer William
July 7, 2026 11:37 AM - SEC Filing
Form 4 CORCEPT THERAPEUTICS For: Jul 01 Filed by: Maduck Sean
July 6, 2026 4:44 PM - SEC Filing
Form 4 CORCEPT THERAPEUTICS For: Jun 16 Filed by: WILSON JAMES N
June 18, 2026 4:31 PM - SEC Filing
Form 4 CORCEPT THERAPEUTICS For: Jun 17 Filed by: MAHONEY DAVID L
June 18, 2026 4:31 PM - SEC Filing
Form 8-K CORCEPT THERAPEUTICS For: Jun 17
June 17, 2026 4:37 PM - SEC Filing
Form 4 CORCEPT THERAPEUTICS For: Jun 15 Filed by: Mokari Atabak
June 17, 2026 4:30 PM - SEC Filing
Corcept resubmits NDA for relacorilant to treat Cushing's syndrome
June 17, 2026 4:28 PM - StreetInsider
Corcept Resubmits New Drug Application for Relacorilant as a Treatment for Patients with Cushing’s Syndrome
June 17, 2026 4:28 PM - BizWire
Form 144 CORCEPT THERAPEUTICS Filed by: MAHONEY DAVID L
June 16, 2026 3:06 PM - SEC Filing
Form 144 CORCEPT THERAPEUTICS Filed by: WILSON JAMES N
June 16, 2026 1:56 PM - SEC Filing
Full Article List
